Global Generic Drugs Supply, Demand and Key Producers, 2023-2029

Description

The global Generic Drugs market size is expected to reach $ 550750 million by 2029, rising at a market growth of 7.9% CAGR during the forecast period (2023-2029).

Market competition is not intense. Teva, Novartis – Sandoz, Mylan, Sun Pharmaceutical and Aspen are the leaders of the industry, with about 19% market shares.

North America is the largest consumption place, with a consumption market share nearly 44%. Following North America, Europe is the second largest consumption place with the consumption market share of 18%.

A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.

This report studies the global Generic Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Generic Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Generic Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Generic Drugs total market, 2018-2029, (USD Million)
Global Generic Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Generic Drugs total market, key domestic companies and share, (USD Million)
Global Generic Drugs revenue by player and market share 2018-2023, (USD Million)
Global Generic Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global Generic Drugs total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Generic Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Novartis, Viatris, Sun Pharmaceutical, Aspen Pharmacare, Fresenius Kabi, Sanofi, Aurobindo and Lupin, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Generic Drugs market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Generic Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Generic Drugs Market, Segmentation by Type
    Oral
    Injection
    Other

Global Generic Drugs Market, Segmentation by Application
    Hospital Pharmacy
    Retail Pharmacy
    Other

Companies Profiled:
    Teva
    Novartis
    Viatris
    Sun Pharmaceutical
    Aspen Pharmacare
    Fresenius Kabi
    Sanofi
    Aurobindo
    Lupin
    Dr. Reddy's
    Apotex
    Cipla
    ENDO
    Stada Arzneimittel
    Bausch Health
    Hikma
    Torrent
    Glenmark
    Piramal Pharma
    Sawai Pharmaceutical

Key Questions Answered
1. How big is the global Generic Drugs market?
2. What is the demand of the global Generic Drugs market?
3. What is the year over year growth of the global Generic Drugs market?
4. What is the total value of the global Generic Drugs market?
5. Who are the major players in the global Generic Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Generic Drugs Introduction
    1.2 World Generic Drugs Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Generic Drugs Total Market by Region (by Headquarter Location)
        1.3.1 World Generic Drugs Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Generic Drugs Market Size (2018-2029)
        1.3.3 China Generic Drugs Market Size (2018-2029)
        1.3.4 Europe Generic Drugs Market Size (2018-2029)
        1.3.5 Japan Generic Drugs Market Size (2018-2029)
        1.3.6 South Korea Generic Drugs Market Size (2018-2029)
        1.3.7 ASEAN Generic Drugs Market Size (2018-2029)
        1.3.8 India Generic Drugs Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Generic Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Generic Drugs Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Generic Drugs Consumption Value (2018-2029)
    2.2 World Generic Drugs Consumption Value by Region
        2.2.1 World Generic Drugs Consumption Value by Region (2018-2023)
        2.2.2 World Generic Drugs Consumption Value Forecast by Region (2024-2029)
    2.3 United States Generic Drugs Consumption Value (2018-2029)
    2.4 China Generic Drugs Consumption Value (2018-2029)
    2.5 Europe Generic Drugs Consumption Value (2018-2029)
    2.6 Japan Generic Drugs Consumption Value (2018-2029)
    2.7 South Korea Generic Drugs Consumption Value (2018-2029)
    2.8 ASEAN Generic Drugs Consumption Value (2018-2029)
    2.9 India Generic Drugs Consumption Value (2018-2029)

3 World Generic Drugs Companies Competitive Analysis
    3.1 World Generic Drugs Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Generic Drugs Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Generic Drugs in 2022
        3.2.3 Global Concentration Ratios (CR8) for Generic Drugs in 2022
    3.3 Generic Drugs Company Evaluation Quadrant
    3.4 Generic Drugs Market: Overall Company Footprint Analysis
        3.4.1 Generic Drugs Market: Region Footprint
        3.4.2 Generic Drugs Market: Company Product Type Footprint
        3.4.3 Generic Drugs Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Generic Drugs Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Generic Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Generic Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Generic Drugs Consumption Value Comparison
        4.2.1 United States VS China: Generic Drugs Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Generic Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Generic Drugs Companies and Market Share, 2018-2023
        4.3.1 United States Based Generic Drugs Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Generic Drugs Revenue, (2018-2023)
    4.4 China Based Companies Generic Drugs Revenue and Market Share, 2018-2023
        4.4.1 China Based Generic Drugs Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Generic Drugs Revenue, (2018-2023)
    4.5 Rest of World Based Generic Drugs Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Generic Drugs Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Generic Drugs Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Generic Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Oral
        5.2.2 Injection
        5.2.3 Other
    5.3 Market Segment by Type
        5.3.1 World Generic Drugs Market Size by Type (2018-2023)
        5.3.2 World Generic Drugs Market Size by Type (2024-2029)
        5.3.3 World Generic Drugs Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Generic Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital Pharmacy
        6.2.2 Retail Pharmacy
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Generic Drugs Market Size by Application (2018-2023)
        6.3.2 World Generic Drugs Market Size by Application (2024-2029)
        6.3.3 World Generic Drugs Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Teva
        7.1.1 Teva Details
        7.1.2 Teva Major Business
        7.1.3 Teva Generic Drugs Product and Services
        7.1.4 Teva Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Teva Recent Developments/Updates
        7.1.6 Teva Competitive Strengths & Weaknesses
    7.2 Novartis
        7.2.1 Novartis Details
        7.2.2 Novartis Major Business
        7.2.3 Novartis Generic Drugs Product and Services
        7.2.4 Novartis Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Novartis Recent Developments/Updates
        7.2.6 Novartis Competitive Strengths & Weaknesses
    7.3 Viatris
        7.3.1 Viatris Details
        7.3.2 Viatris Major Business
        7.3.3 Viatris Generic Drugs Product and Services
        7.3.4 Viatris Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Viatris Recent Developments/Updates
        7.3.6 Viatris Competitive Strengths & Weaknesses
    7.4 Sun Pharmaceutical
        7.4.1 Sun Pharmaceutical Details
        7.4.2 Sun Pharmaceutical Major Business
        7.4.3 Sun Pharmaceutical Generic Drugs Product and Services
        7.4.4 Sun Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Sun Pharmaceutical Recent Developments/Updates
        7.4.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
    7.5 Aspen Pharmacare
        7.5.1 Aspen Pharmacare Details
        7.5.2 Aspen Pharmacare Major Business
        7.5.3 Aspen Pharmacare Generic Drugs Product and Services
        7.5.4 Aspen Pharmacare Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Aspen Pharmacare Recent Developments/Updates
        7.5.6 Aspen Pharmacare Competitive Strengths & Weaknesses
    7.6 Fresenius Kabi
        7.6.1 Fresenius Kabi Details
        7.6.2 Fresenius Kabi Major Business
        7.6.3 Fresenius Kabi Generic Drugs Product and Services
        7.6.4 Fresenius Kabi Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Fresenius Kabi Recent Developments/Updates
        7.6.6 Fresenius Kabi Competitive Strengths & Weaknesses
    7.7 Sanofi
        7.7.1 Sanofi Details
        7.7.2 Sanofi Major Business
        7.7.3 Sanofi Generic Drugs Product and Services
        7.7.4 Sanofi Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Sanofi Recent Developments/Updates
        7.7.6 Sanofi Competitive Strengths & Weaknesses
    7.8 Aurobindo
        7.8.1 Aurobindo Details
        7.8.2 Aurobindo Major Business
        7.8.3 Aurobindo Generic Drugs Product and Services
        7.8.4 Aurobindo Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Aurobindo Recent Developments/Updates
        7.8.6 Aurobindo Competitive Strengths & Weaknesses
    7.9 Lupin
        7.9.1 Lupin Details
        7.9.2 Lupin Major Business
        7.9.3 Lupin Generic Drugs Product and Services
        7.9.4 Lupin Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Lupin Recent Developments/Updates
        7.9.6 Lupin Competitive Strengths & Weaknesses
    7.10 Dr. Reddy's
        7.10.1 Dr. Reddy's Details
        7.10.2 Dr. Reddy's Major Business
        7.10.3 Dr. Reddy's Generic Drugs Product and Services
        7.10.4 Dr. Reddy's Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Dr. Reddy's Recent Developments/Updates
        7.10.6 Dr. Reddy's Competitive Strengths & Weaknesses
    7.11 Apotex
        7.11.1 Apotex Details
        7.11.2 Apotex Major Business
        7.11.3 Apotex Generic Drugs Product and Services
        7.11.4 Apotex Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Apotex Recent Developments/Updates
        7.11.6 Apotex Competitive Strengths & Weaknesses
    7.12 Cipla
        7.12.1 Cipla Details
        7.12.2 Cipla Major Business
        7.12.3 Cipla Generic Drugs Product and Services
        7.12.4 Cipla Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Cipla Recent Developments/Updates
        7.12.6 Cipla Competitive Strengths & Weaknesses
    7.13 ENDO
        7.13.1 ENDO Details
        7.13.2 ENDO Major Business
        7.13.3 ENDO Generic Drugs Product and Services
        7.13.4 ENDO Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 ENDO Recent Developments/Updates
        7.13.6 ENDO Competitive Strengths & Weaknesses
    7.14 Stada Arzneimittel
        7.14.1 Stada Arzneimittel Details
        7.14.2 Stada Arzneimittel Major Business
        7.14.3 Stada Arzneimittel Generic Drugs Product and Services
        7.14.4 Stada Arzneimittel Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Stada Arzneimittel Recent Developments/Updates
        7.14.6 Stada Arzneimittel Competitive Strengths & Weaknesses
    7.15 Bausch Health
        7.15.1 Bausch Health Details
        7.15.2 Bausch Health Major Business
        7.15.3 Bausch Health Generic Drugs Product and Services
        7.15.4 Bausch Health Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Bausch Health Recent Developments/Updates
        7.15.6 Bausch Health Competitive Strengths & Weaknesses
    7.16 Hikma
        7.16.1 Hikma Details
        7.16.2 Hikma Major Business
        7.16.3 Hikma Generic Drugs Product and Services
        7.16.4 Hikma Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 Hikma Recent Developments/Updates
        7.16.6 Hikma Competitive Strengths & Weaknesses
    7.17 Torrent
        7.17.1 Torrent Details
        7.17.2 Torrent Major Business
        7.17.3 Torrent Generic Drugs Product and Services
        7.17.4 Torrent Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.17.5 Torrent Recent Developments/Updates
        7.17.6 Torrent Competitive Strengths & Weaknesses
    7.18 Glenmark
        7.18.1 Glenmark Details
        7.18.2 Glenmark Major Business
        7.18.3 Glenmark Generic Drugs Product and Services
        7.18.4 Glenmark Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.18.5 Glenmark Recent Developments/Updates
        7.18.6 Glenmark Competitive Strengths & Weaknesses
    7.19 Piramal Pharma
        7.19.1 Piramal Pharma Details
        7.19.2 Piramal Pharma Major Business
        7.19.3 Piramal Pharma Generic Drugs Product and Services
        7.19.4 Piramal Pharma Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.19.5 Piramal Pharma Recent Developments/Updates
        7.19.6 Piramal Pharma Competitive Strengths & Weaknesses
    7.20 Sawai Pharmaceutical
        7.20.1 Sawai Pharmaceutical Details
        7.20.2 Sawai Pharmaceutical Major Business
        7.20.3 Sawai Pharmaceutical Generic Drugs Product and Services
        7.20.4 Sawai Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.20.5 Sawai Pharmaceutical Recent Developments/Updates
        7.20.6 Sawai Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Generic Drugs Industry Chain
    8.2 Generic Drugs Upstream Analysis
    8.3 Generic Drugs Midstream Analysis
    8.4 Generic Drugs Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Generic Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Generic Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Generic Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Generic Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Generic Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Generic Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Generic Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Generic Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Generic Drugs Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Generic Drugs Players in 2022
    Table 12. World Generic Drugs Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Generic Drugs Company Evaluation Quadrant
    Table 14. Head Office of Key Generic Drugs Player
    Table 15. Generic Drugs Market: Company Product Type Footprint
    Table 16. Generic Drugs Market: Company Product Application Footprint
    Table 17. Generic Drugs Mergers & Acquisitions Activity
    Table 18. United States VS China Generic Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Generic Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Generic Drugs Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Generic Drugs Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Generic Drugs Revenue Market Share (2018-2023)
    Table 23. China Based Generic Drugs Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Generic Drugs Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Generic Drugs Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Generic Drugs Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Generic Drugs Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Generic Drugs Revenue Market Share (2018-2023)
    Table 29. World Generic Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Generic Drugs Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Generic Drugs Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Generic Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Generic Drugs Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Generic Drugs Market Size by Application (2024-2029) & (USD Million)
    Table 35. Teva Basic Information, Area Served and Competitors
    Table 36. Teva Major Business
    Table 37. Teva Generic Drugs Product and Services
    Table 38. Teva Generic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Teva Recent Developments/Updates
    Table 40. Teva Competitive Strengths & Weaknesses
    Table 41. Novartis Basic Information, Area Served and Competitors
    Table 42. Novartis Major Business
    Table 43. Novartis Generic Drugs Product and Services
    Table 44. Novartis Generic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Novartis Recent Developments/Updates
    Table 46. Novartis Competitive Strengths & Weaknesses
    Table 47. Viatris Basic Information, Area Served and Competitors
    Table 48. Viatris Major Business
    Table 49. Viatris Generic Drugs Product and Services
    Table 50. Viatris Generic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Viatris Recent Developments/Updates
    Table 52. Viatris Competitive Strengths & Weaknesses
    Table 53. Sun Pharmaceutical Basic Information, Area Served and Competitors
    Table 54. Sun Pharmaceutical Major Business
    Table 55. Sun Pharmaceutical Generic Drugs Product and Services
    Table 56. Sun Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Sun Pharmaceutical Recent Developments/Updates
    Table 58. Sun Pharmaceutical Competitive Strengths & Weaknesses
    Table 59. Aspen Pharmacare Basic Information, Area Served and Competitors
    Table 60. Aspen Pharmacare Major Business
    Table 61. Aspen Pharmacare Generic Drugs Product and Services
    Table 62. Aspen Pharmacare Generic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Aspen Pharmacare Recent Developments/Updates
    Table 64. Aspen Pharmacare Competitive Strengths & Weaknesses
    Table 65. Fresenius Kabi Basic Information, Area Served and Competitors
    Table 66. Fresenius Kabi Major Business
    Table 67. Fresenius Kabi Generic Drugs Product and Services
    Table 68. Fresenius Kabi Generic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Fresenius Kabi Recent Developments/Updates
    Table 70. Fresenius Kabi Competitive Strengths & Weaknesses
    Table 71. Sanofi Basic Information, Area Served and Competitors
    Table 72. Sanofi Major Business
    Table 73. Sanofi Generic Drugs Product and Services
    Table 74. Sanofi Generic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Sanofi Recent Developments/Updates
    Table 76. Sanofi Competitive Strengths & Weaknesses
    Table 77. Aurobindo Basic Information, Area Served and Competitors
    Table 78. Aurobindo Major Business
    Table 79. Aurobindo Generic Drugs Product and Services
    Table 80. Aurobindo Generic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Aurobindo Recent Developments/Updates
    Table 82. Aurobindo Competitive Strengths & Weaknesses
    Table 83. Lupin Basic Information, Area Served and Competitors
    Table 84. Lupin Major Business
    Table 85. Lupin Generic Drugs Product and Services
    Table 86. Lupin Generic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Lupin Recent Developments/Updates
    Table 88. Lupin Competitive Strengths & Weaknesses
    Table 89. Dr. Reddy's Basic Information, Area Served and Competitors
    Table 90. Dr. Reddy's Major Business
    Table 91. Dr. Reddy's Generic Drugs Product and Services
    Table 92. Dr. Reddy's Generic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Dr. Reddy's Recent Developments/Updates
    Table 94. Dr. Reddy's Competitive Strengths & Weaknesses
    Table 95. Apotex Basic Information, Area Served and Competitors
    Table 96. Apotex Major Business
    Table 97. Apotex Generic Drugs Product and Services
    Table 98. Apotex Generic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Apotex Recent Developments/Updates
    Table 100. Apotex Competitive Strengths & Weaknesses
    Table 101. Cipla Basic Information, Area Served and Competitors
    Table 102. Cipla Major Business
    Table 103. Cipla Generic Drugs Product and Services
    Table 104. Cipla Generic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Cipla Recent Developments/Updates
    Table 106. Cipla Competitive Strengths & Weaknesses
    Table 107. ENDO Basic Information, Area Served and Competitors
    Table 108. ENDO Major Business
    Table 109. ENDO Generic Drugs Product and Services
    Table 110. ENDO Generic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. ENDO Recent Developments/Updates
    Table 112. ENDO Competitive Strengths & Weaknesses
    Table 113. Stada Arzneimittel Basic Information, Area Served and Competitors
    Table 114. Stada Arzneimittel Major Business
    Table 115. Stada Arzneimittel Generic Drugs Product and Services
    Table 116. Stada Arzneimittel Generic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Stada Arzneimittel Recent Developments/Updates
    Table 118. Stada Arzneimittel Competitive Strengths & Weaknesses
    Table 119. Bausch Health Basic Information, Area Served and Competitors
    Table 120. Bausch Health Major Business
    Table 121. Bausch Health Generic Drugs Product and Services
    Table 122. Bausch Health Generic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. Bausch Health Recent Developments/Updates
    Table 124. Bausch Health Competitive Strengths & Weaknesses
    Table 125. Hikma Basic Information, Area Served and Competitors
    Table 126. Hikma Major Business
    Table 127. Hikma Generic Drugs Product and Services
    Table 128. Hikma Generic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 129. Hikma Recent Developments/Updates
    Table 130. Hikma Competitive Strengths & Weaknesses
    Table 131. Torrent Basic Information, Area Served and Competitors
    Table 132. Torrent Major Business
    Table 133. Torrent Generic Drugs Product and Services
    Table 134. Torrent Generic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 135. Torrent Recent Developments/Updates
    Table 136. Torrent Competitive Strengths & Weaknesses
    Table 137. Glenmark Basic Information, Area Served and Competitors
    Table 138. Glenmark Major Business
    Table 139. Glenmark Generic Drugs Product and Services
    Table 140. Glenmark Generic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 141. Glenmark Recent Developments/Updates
    Table 142. Glenmark Competitive Strengths & Weaknesses
    Table 143. Piramal Pharma Basic Information, Area Served and Competitors
    Table 144. Piramal Pharma Major Business
    Table 145. Piramal Pharma Generic Drugs Product and Services
    Table 146. Piramal Pharma Generic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 147. Piramal Pharma Recent Developments/Updates
    Table 148. Sawai Pharmaceutical Basic Information, Area Served and Competitors
    Table 149. Sawai Pharmaceutical Major Business
    Table 150. Sawai Pharmaceutical Generic Drugs Product and Services
    Table 151. Sawai Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 152. Global Key Players of Generic Drugs Upstream (Raw Materials)
    Table 153. Generic Drugs Typical Customers
List of Figure
    Figure 1. Generic Drugs Picture
    Figure 2. World Generic Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Generic Drugs Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Generic Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Generic Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Generic Drugs Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Generic Drugs Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Generic Drugs Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Generic Drugs Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Generic Drugs Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Generic Drugs Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Generic Drugs Revenue (2018-2029) & (USD Million)
    Figure 13. Generic Drugs Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Generic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Generic Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Generic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Generic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Generic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Generic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Generic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Generic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Generic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Generic Drugs by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Generic Drugs Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Generic Drugs Markets in 2022
    Figure 27. United States VS China: Generic Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Generic Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Generic Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Generic Drugs Market Size Market Share by Type in 2022
    Figure 31. Oral
    Figure 32. Injection
    Figure 33. Other
    Figure 34. World Generic Drugs Market Size Market Share by Type (2018-2029)
    Figure 35. World Generic Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World Generic Drugs Market Size Market Share by Application in 2022
    Figure 37. Hospital Pharmacy
    Figure 38. Retail Pharmacy
    Figure 39. Other
    Figure 40. Generic Drugs Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Companies Mentioned

Teva
Novartis
Viatris
Sun Pharmaceutical
Aspen Pharmacare
Fresenius Kabi
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO
Stada Arzneimittel
Bausch Health
Hikma
Torrent
Glenmark
Piramal Pharma
Sawai Pharmaceutical